Skip to main content

Acurx Pharmaceuticals, Inc.

ACXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001736243

No open-market purchases or sales by Acurx Pharmaceuticals, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $185.5K in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Acurx Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Acurx Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Acurx Pharmaceuticals, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Deluccia Robert JDirector1,010,196Apr 22, 20261
Harrison Thomas LDirector–Apr 22, 20261
Luci David PPresident and CEO1,097,458Apr 22, 20261
Scodari Joseph CDirector27,708Apr 22, 20261
Dean Jack HDirector21,776Apr 22, 20261
Shawah Robert G.Chief Financial Officer–Apr 22, 20261
Sailer CarlDirector137,183Apr 22, 20261
Donohue James J.Director22,352Apr 22, 20261

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 8, 2025 (view filing)Jan 62 daysScodari Joseph CDirectorPPurchase+24.6K$1.02+$25.1K+800.5%27.7K after
Jan 8, 2025 (view filing)Jan 62 daysScodari Joseph CDirectorPPurchase+24.6K$0.00$0–24.6K afterDerivative
Jan 8, 2025 (view filing)Jan 62 daysSailer CarlDirectorPPurchase+24.6K$1.02+$25.1K+21.9%137.2K after
Jan 8, 2025 (view filing)Jan 62 daysSailer CarlDirectorPPurchase+24.6K$0.00$0–24.6K afterDerivative
Jan 8, 2025 (view filing)Jan 62 daysLuci David PPresident and CEOPPurchase+49.3K$1.02+$50.2K+4.7%1.10M after
Jan 8, 2025 (view filing)Jan 62 daysLuci David PPresident and CEOPPurchase+49.3K$0.00$0–49.3K afterDerivative
Jan 8, 2025 (view filing)Jan 62 daysDonohue James J.DirectorPPurchase+9.85K$1.02+$10.0K+78.8%22.4K after
Jan 8, 2025 (view filing)Jan 62 daysDonohue James J.DirectorPPurchase+9.85K$0.00$0–9.85K afterDerivative
Jan 8, 2025 (view filing)Jan 62 daysDeluccia Robert JDirector, 10% OwnerPPurchase+49.3K$1.02+$50.2K+5.1%1.01M after
Jan 8, 2025 (view filing)Jan 62 daysDeluccia Robert JDirector, 10% OwnerPPurchase+49.3K$0.00$0–49.3K afterDerivative
Jan 8, 2025 (view filing)Jan 62 daysDean Jack HDirectorPPurchase+9.85K$1.02+$10.0K+82.6%21.8K after
Jan 8, 2025 (view filing)Jan 62 daysDean Jack HDirectorPPurchase+9.85K$0.00$0–9.85K afterDerivative
Jul 29, 2022 (view filing)Jul 272 daysSailer CarlDirectorPPurchase+19.7K$3.80+$75.0K+27.0%92.8K after
Jul 29, 2022 (view filing)Jul 272 daysSailer CarlDirectorPPurchase+39.5K$0.00$0–19.7K afterDerivative2 lots
Jul 29, 2022 (view filing)Jul 272 daysDeluccia Robert JDirector, 10% OwnerPPurchase+19.7K$3.80+$75.0K+1.9%1.05M after
Jul 29, 2022 (view filing)Jul 272 daysDeluccia Robert JDirector, 10% OwnerPPurchase+39.5K$0.00$0–19.7K afterDerivative2 lots
Jul 29, 2022 (view filing)Jul 272 daysLuci David PPresident and CEOPPurchase+19.7K$3.80+$75.0K+2.0%1.03M after
Jul 29, 2022 (view filing)Jul 272 daysLuci David PPresident and CEOPPurchase+39.5K$0.00$0–19.7K afterDerivative2 lots
Nov 24, 2021 (view filing)Nov 231 daySailer CarlDirectorPPurchase+5.16K$4.84+$25.0K+7.6%73.1K after
Nov 22, 2021 (view filing)Nov 193 daysDeluccia Robert JDirector, 10% OwnerPPurchase+5.03K$4.90+$24.7K+0.5%1.03M after
Nov 22, 2021 (view filing)Nov 193 daysLuci David PPresident and CEOPPurchase+5.20K$4.80+$25.0K+0.5%1.01M after
Sep 10, 2021 (view filing)Jun 2973 daysLateSailer CarlDirectorPPurchase+12.5K$6.00+$75.0K+22.6%67.9K after